The influence of NK alloreactivity on matched unrelated donor and HLA identical sibling haematopoietic stem cell transplantation.
Numerous retrospective studies have been reported analysing the role of HLA mismatches that confer donor NK alloreactivity towards the recipient on the outcome of haematopoietic stem cell transplantation. A bewildering variety of findings have been observed with different studies showing either beneficial or deleterious effects on outcome. This review organises the reports into those that use similar definitions of NK alloreactivity, suggests possible reasons for such disparate results and assesses whether any recommendations can be made in relation to donor selection. There is growing evidence that the effect of human NK alloreactivity on outcome is transplant protocol dependent. Protocol variables most likely to affect outcome are those that influence donor T cell numbers. At this time, it is not possible to predict how the outcome of unrelated donor transplantation will be affected by HLA mismatches conferring potential donor NK alloreactivity.
Witt
Campbell S
CS
Department of Clinical Immunology and Immunogenetics, PathWest, Royal Perth Hospital, School of Pathology and Laboratory Medicine, University of Western Australia, Australia. campbell.witt@health.wa.gov.au
D046148:Donor Selection / Q000379:methods; D006084:Graft Rejection / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006650:Histocompatibility Testing; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D035781:Siblings; D014019:Tissue Donors; D014184:Transplantation, Homologous
D006680:HLA Antigens